An investigation on behalf of investors of Thoratec Corporation (NASDAQ:THOR) in connection with the proposed takeover was announced and NASDAQ:THOR stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 08/05/2015 --An investigation for investors in NASDAQ:THOR shares was announced concerning whether the takeover of Thoratec Corporation by St. Jude Medical for $63.50 per share is unfair.

On July 22, 2015, St. Jude Medical (NYSE:STJ) and Thoratec Corporation (NASDAQ:THOR) announced that the Boards of Directors of both companies have unanimously approved an agreement under which St. Jude Medical will acquire all of the outstanding shares of Thoratec for $63.50 per share in a cash transaction valued at approximately $3.4 billion, net of cash acquired.

Investors who purchased shares of Thoratec Corporation (NASDAQ:THOR) and currently hold any of those NASDAQ:THOR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain officers and directors of Thoratec Corporation breached their fiduciary duties owed to NASDAQ:THOR investors in connection with the proposed acquisition.

However, the investigation concerns whether the offer is unfair to NASDAQ:THOR stockholders. More specifically, the investigation concerns whether the Thoratec Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Shares of Thoratec Corporation (NASDAQ:THOR) closed on August 3, 2015, as $63.23 per share.

Those who are current investors in Thoratec Corporation (NASDAQ:THOR) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com